These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3220320)

  • 41. Immunoaffinity purification and characterisation of p29--an estrogen receptor related protein.
    Hayward JR; Coffer AI; King RJ
    J Steroid Biochem Mol Biol; 1990 Nov; 37(4):513-9. PubMed ID: 2278835
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Estrogen receptors and human bone cells: immunocytochemical studies.
    Colston KW; King RJ; Hayward J; Fraser DI; Horton MA; Stevenson JC; Arnett TR
    J Bone Miner Res; 1989 Aug; 4(4):625-31. PubMed ID: 2479230
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Measurement of estrogen and progesterone receptors in human breast tumors: enzyme immunoassay versus binding assay.
    Holmes FA; Fritsche HA; Loewy JW; Geitner AM; Sutton RC; Buzdar AU; Hortobagyi GN
    J Clin Oncol; 1990 Jun; 8(6):1025-35. PubMed ID: 2189952
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of estrogen receptors, progesterone receptors, and an estrogen receptor-associated protein in the human cervix during the menstrual cycle and menopause.
    Cano A; Serra V; Rivera J; Monmeneu R; Marzo C
    Fertil Steril; 1990 Dec; 54(6):1058-64. PubMed ID: 1700956
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Correlation between receptor status histochemically determined and clinical course in tumors of the breast: execution and extension of the study].
    Gottardi O; Franchi L; Ghislandi E
    Pathologica; 1987; 79(1059-1060):141-7. PubMed ID: 3441404
    [No Abstract]   [Full Text] [Related]  

  • 46. Menopausal status and cut off levels of steroid receptor ligand binding assays in breast cancer.
    Norgren A; Forsberg AH; Lindgren A; Sällström JF
    Anticancer Res; 1989; 9(1):173-6. PubMed ID: 2495752
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of an enzyme immunoassay for estrogen receptors in human breast cancers.
    Nicholson RI; Colin P; Francis AB; Keshra R; Finlay P; Williams M; Elston CW; Blamey RW; Griffiths K
    Cancer Res; 1986 Aug; 46(8 Suppl):4299s-4302s. PubMed ID: 3524811
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunological quantitation of nuclear receptors in human breast cancer: relation to cytosolic estrogen and progesterone receptors.
    Thorpe SM
    Cancer Res; 1987 Apr; 47(7):1830-5. PubMed ID: 3545455
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Estrogen-receptor-related protein p29 in primary nonsmall cell lung carcinoma: pathologic and prognostic correlations.
    Vargas SO; Leslie KO; Vacek PM; Socinski MA; Weaver DL
    Cancer; 1998 Apr; 82(8):1495-500. PubMed ID: 9554526
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparison of enzyme immunoassay and tritiated steroid binding assay for estrogen and progesterone receptor in 56 breast cancer cytosols].
    Noguchi S; Miyauchi K; Nishizawa Y; Koyama H
    Nihon Gan Chiryo Gakkai Shi; 1988 Jun; 23(6):1257-64. PubMed ID: 3068322
    [No Abstract]   [Full Text] [Related]  

  • 51. [Enzyme immunoassay and radioimmunoassay using monoclonal antibody for the determination of estrogen receptors in human breast cancer].
    Ohnami S; Nakayama C; Ohnami S; Zeze F; Eto S
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3447-52. PubMed ID: 3539025
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estradiol and progesterone receptors in human breast cancer.
    Mureşan Z; Voiculetz N
    Neoplasma; 1985; 32(2):217-24. PubMed ID: 4000310
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
    Pujol P; Daures JP; Thezenas S; Guilleux F; Rouanet P; Grenier J
    Cancer; 1998 Aug; 83(4):698-705. PubMed ID: 9708933
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors associated with prognosis in human breast cancer. IV. Progesterone receptors and clinical factors.
    Macías A; Pascual MR; Pérez R; Lage A
    Neoplasma; 1983; 30(5):593-601. PubMed ID: 6656963
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantitative enzyme-linked immunosorbent assay for the estrogen-regulated Mr 24,000 protein in human breast tumors: correlation with estrogen and progesterone receptors.
    Adams DJ; McGuire WL
    Cancer Res; 1985 Jun; 45(6):2445-9. PubMed ID: 3886134
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Steroid hormone receptors and sex chromatin frequency in breast cancer.
    Smethurst M; Bishun NP; Fernandez D; Allen J; Burn JI; Alaghband-Zadeh J; Williams DC
    J Endocrinol Invest; 1981; 4(4):455-7. PubMed ID: 7334186
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Sex hormone-binding globulin in breast cancer].
    Suminaga Y; Morimoto T; Komaki K; Mori T; Monden Y
    Nihon Geka Gakkai Zasshi; 1990 Jul; 91(7):875-82. PubMed ID: 2398880
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elastosis and steroid receptors in primary breast cancer.
    Lima-de-Almeida FM; Brentani MM; Velludo MA; Goes JC; Baruffi I
    Braz J Med Biol Res; 1985; 18(3):279-83. PubMed ID: 3835979
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship of monoclonal antibody binding to estrogen and progesterone receptor content in breast cancer.
    Hendler FJ; Yuan D
    Cancer Res; 1985 Jan; 45(1):421-9. PubMed ID: 3965148
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The prognostic value of the monoclonal antibody (D5) detected protein, p29, in primary colorectal carcinoma.
    Robertson JF; Morris DL; Ellis IO; Armitage NC; Hardcastle JD
    Br J Cancer; 1991 Aug; 64(2):379-80. PubMed ID: 1892769
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.